🟢 Telix Pharmaceuticals is trading 4.38% up with no clear company-specific catalyst

Telix Pharmaceuticals is trading at A$13.35, up 4.38%, with no major company-specific announcement identified for October 28. - The provided last close was A$13.06, up 2.11%; the latest ASX filing was a small securities-quotation application. - A recent CEO purchase of nearly A$500,000 may support sentiment, but reporting does not establish it as the cause of this session’s move. - Biotech’s 2.18% sector rise offers supportive context but does not establish the stock’s specific catalyst.